Therapeutic management of MOG-IgG associated disorders. *Benefit–risk... | Download Scientific Diagram
Vicente Martín on Twitter: "MOG in NMOSD Patients They have a different immunopathogenic mechanism in MOG-IgG–positive Neuromyelitis Optica Spectrum Disorders patients With some clinical, epidemiologic, and radiologic features distinct from those in
Myelin oligodendrocyte glycoprotein antibodies in neurological disease | Nature Reviews Neurology
Clinical Characteristics and Treatment of MOG-IgG–Associated Optic Neuritis | SpringerLink
Refining cell-based assay to detect MOG-IgG in patients with central nervous system inflammatory diseases - ScienceDirect
Neuromyelitis optica MOG-IgG causes reversible lesions in mouse brain | Acta Neuropathologica Communications | Full Text
Myelin oligodendrocyte glycoprotein immunoglobulin G‐associated disease: An overview - Fujihara - 2018 - Clinical and Experimental Neuroimmunology - Wiley Online Library
Brain lesions caused by MOG-IgG and AQP4-IgG. Mice received... | Download Scientific Diagram
The serum from a patient with human MOG-IgG shows a widespread... | Download Scientific Diagram
Recent developments in MOG-IgG associated neurological disorders | Semantic Scholar
Beyond Aquaporin and MOG- Novel brain reactive antibodies and B cell responses in Neuromyelitis optica spectrum disorders | Else Kröner-Fresenius-Stiftung
Diagnostic features of initial demyelinating events associated with serum MOG-IgG - ScienceDirect
Anti-MOG autoantibodies pathogenicity in children and macaques demyelinating diseases | Journal of Neuroinflammation | Full Text
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: practical considerations | Practical Neurology
Corrected CSF/Serum MOG-IgG Index, Lesion Location, and Clinical... | Download Scientific Diagram
Study identifies clinical phenotype, visual outcomes of MOG-IgG antibody optic neuritis - Mayo Clinic
Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis | PNAS
Neurological update: MOG antibody disease | SpringerLink
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin – topic of research
Frontiers | Age-Related Clinical Presentation of MOG-IgG Seropositivity in Israel
SensoLyte® Anti-Mouse MOG (1-125) IgG Quantitative ELISA Kit Colorimetric - 1 kit
Frontiers | Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disorders: Toward a New Spectrum of Inflammatory Demyelinating CNS Disorders?
